Skip to content
Recall Observatory FDA recall evidence

Derived label

Unknown

Spectrazyme, 180 count, 60 count, 12 bottles/case, 20000 tablets/box, 14000 capsules/pail.

reason.no_named_rule

v1.0.0

Assignment summary

Mode key
unknown
Evidence excerpt
Metagenics is recalling Spectrazyme because their raw material supplier informed them that enzymes in the blend may contain the antibiotic chloramphenicol.
Rule explanation
A recall reason is available, but none of the published named rules supports a failure-mode interpretation.
Firm
Metagenics, Inc.

Field note

Send feedback

We'll only use this to respond to your feedback.